Nathaniel Jonathan Berky: New Protein-Binding Insight May Transform Personalised IVF
Nathaniel Jonathan Berky, Venture Architect, shared a post on LinkedIn:
“This is an important advance for reproductive health.
Understanding fertilisation at this molecular-mechanical level brings us closer to a truly personalised IVF journey in which fit-for-purpose treatment (rather than ‘unexplained’) can be identified within a failed cycle.
If this protein-binding mechanism can be verified in the clinic, it could shorten the trial and error aspect of treatment, improve IVF success rates, and change how we screen patients to prepare them for a cycle.
Switzerland is well placed for this next stage: we have good research (Basel, ETH-Department of Biosystems Science and Engineering (D-BSSE)), the biotech translation capacity, and a patient group who would expect evidence-based care than just fertility standard protocols.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 13, 2026, 15:11Sachintha Alwis: From Impaired Sperm Motility to Microrobotics
-
Sep 13, 2026, 15:08Laurence Orbuch: Before Endometriosis Surgery, Ask…
-
Sep 13, 2026, 15:05Ademola Ayodele: IUI, IVF or Egg Freezing – Which One Is Right for You?
-
Sep 13, 2026, 14:59Fiona Pathiraja-Møller: Tennis Players No Longer Have to Choose Between Career and Family
-
Sep 13, 2026, 14:571-Day Virtual Experience for People Impacted by PMOS – PCOS Awareness Association
-
Sep 13, 2026, 14:53Ozor Victor: Behind Every Embryo Is a Story of Science, Precision, and Hope
-
Sep 13, 2026, 14:50Diana Kayal: What They Don’t Tell You About IVF
-
Sep 13, 2026, 14:44Vikram Sinai Talaulikar: A Heartfelt Thank You to All Who Donated and Supported “Menopause and Cancer”
-
Sep 13, 2026, 14:41Nicole McPherson: Changing IVF Practices Is Hard – Integration Needs to Be Easy
